Your browser doesn't support javascript.
loading
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Kim, Michelle M; Mehta, Minesh P; Smart, DeeDee K; Steeg, Patricia S; Hong, Julie A; Espey, Michael G; Prasanna, Pataje G; Crandon, Laura; Hodgdon, Christine; Kozak, Niki; Armstrong, Terri S; Morikawa, Aki; Willmarth, Nicole; Tanner, Kirk; Boire, Adrienne; Gephart, Melanie Hayden; Margolin, Kim A; Hattangadi-Gluth, Jona; Tawbi, Hussein; Trifiletti, Daniel M; Chung, Caroline; Basu-Roy, Upal; Burns, Robyn; Oliva, Isabella C Glitza; Aizer, Ayal A; Anders, Carey K; Davis, Joanne; Ahluwalia, Manmeet S; Chiang, Veronica; Li, Jing; Kotecha, Rupesh; Formenti, Silvia C; Ellingson, Benjamin M; Gondi, Vinai; Sperduto, Paul W; Barnholtz-Sloan, Jill S; Rodon, Jordi; Lee, Eudocia Q; Khasraw, Mustafa; Yeboa, Debra Nana; Brastianos, Priscilla K; Galanis, Evanthia; Coleman, C Norman; Ahmed, Mansoor M.
Afiliación
  • Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. Electronic address: michekim@med.umich.edu.
  • Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
  • Smart DK; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Steeg PS; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hong JA; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
  • Espey MG; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
  • Prasanna PG; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
  • Crandon L; Touch4Life, Clarksville, MD, USA.
  • Hodgdon C; GRASP, Baltimore, MD, USA.
  • Kozak N; Santa Maria, CA, USA.
  • Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Morikawa A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Willmarth N; American Brain Tumor Association, Chicago, IL, USA.
  • Tanner K; National Brain Tumor Society, Newton, MA, USA.
  • Boire A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gephart MH; Department of Neurosurgery, Stanford University, Stanford, CA, USA.
  • Margolin KA; St John's Cancer Institute, Santa Monica, CA, USA.
  • Hattangadi-Gluth J; Department of Radiation Oncology, University of California San Diego Health, La Jolla, CA, USA.
  • Tawbi H; Department of Melanoma Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Trifiletti DM; Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Chung C; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Basu-Roy U; LUNGevity Foundation, Chicago, IL, USA.
  • Burns R; Melanoma Research Foundation, Washington, DC, USA.
  • Oliva ICG; Department of Melanoma Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aizer AA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
  • Anders CK; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Davis J; The Radiosurgery Society, San Jose, CA, USA.
  • Ahluwalia MS; Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
  • Chiang V; Department of Neurosurgery and Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.
  • Li J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
  • Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Gondi V; Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL, USA.
  • Sperduto PW; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
  • Barnholtz-Sloan JS; Informatics and Data Science Program, Center for Biomedical Informatics and Information Technology, Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Rodon J; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Khasraw M; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
  • Yeboa DN; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Brastianos PK; Division of Hematology/Oncology and Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Galanis E; Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA.
  • Coleman CN; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
  • Ahmed MM; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA. Electronic address: ahmedmm@mail.nih.gov.
Lancet Oncol ; 24(8): e344-e354, 2023 08.
Article en En | MEDLINE | ID: mdl-37541280
ABSTRACT
Brain metastases are an increasing global public health concern, even as survival rates improve for patients with metastatic disease. Both metastases and the sequelae of their treatment are key determinants of the inter-related priorities of patient survival, function, and quality of life, mandating a multidimensional approach to clinical care and research. At a virtual National Cancer Institute Workshop in September, 2022, key stakeholders convened to define research priorities to address the crucial areas of unmet need for patients with brain metastases to achieve meaningful advances in patient outcomes. This Policy Review outlines existing knowledge gaps, collaborative opportunities, and specific recommendations regarding consensus priorities and future directions in brain metastases research. Achieving major advances in research will require enhanced coordination between the ongoing efforts of individual organisations and consortia. Importantly, the continual and active engagement of patients and patient advocates will be necessary to ensure that the directionality of all efforts reflects what is most meaningful in the context of patient care.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Investigación Biomédica Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Investigación Biomédica Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article